Brenner Robert's Form 4 filing
Vera Therapeutics, Inc. (VERA) · filed Feb 25, 2026
- Accession no.
- 0002006910-26-000004
- Filed
- Feb 25, 2026
- Trade date
- Feb 23, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $90.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Brenner RobertCIK 0002006910 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | Class A Common Stock | SSaleDisposed | −2,151 | $41.98 | −$90,298.98 | 50,947 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.